Teva : TEVA

All Teva Articles

450 Articles

Jon C. Ogg | Sep 2, 2016 at 9:10 AM EDT

Top Analyst Upgrades and Downgrades: Carnival, Ciena, MercadoLibre, Spark Therapeutics, Smith & Wesson, Teva, Verifone and More

The top analyst upgrades, downgrades and initiations seen on Friday morning include Carnival, Ciena, MercadoLibre, Spark Therapeutics, Smith & Wesson,…

Jon C. Ogg | Aug 25, 2016 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: DDR, HP, L-3 Communications, Salesforce.com, Teva, Twilio and More

The top analyst upgrades, downgrades and initiations seen on Thursday morning include DDR, HP, L-3 Communications, Salesforce.com, Teva Pharmaceutical and…

Chris Lange | Aug 25, 2016 at 8:45 AM EDT

Major Pharma Short Interest Faces Significant Drop

The August 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Chris Lange | Aug 10, 2016 at 9:05 AM EDT

Major Pharma Short Interest Slides

The July 29 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Paul Ausick | Aug 8, 2016 at 7:55 AM EDT

Why Allergan Earnings Aren’t Telling the Whole Story

Allergan reported mixed second-quarter 2016 results and announced share buybacks before markets opened Monday morning.

Jon C. Ogg | Aug 5, 2016 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: FireEye, Occidental Petroleum, SeaWorld, Teva Pharma, Windstream, Zynga and More

The top analyst upgrades, downgrades and initiations seen on Friday morning include FireEye, Occidental Petroleum, SeaWorld, Teva Pharmaceutical, Windstream and…

Chris Lange | Aug 3, 2016 at 12:50 PM EDT

What Expect From Teva Earnings

Teva Pharmaceutical Industries is scheduled to release its second-quarter financial results before the markets open on Thursday.

Chris Lange | Jul 31, 2016 at 10:50 AM EDT

The Top 10 Earnings for the Week Ahead

24/7 Wall St. has put together a preview of Pfizer, Chesapeake Energy and other major companies reporting their quarterly results…

Chris Lange | Jul 27, 2016 at 8:25 AM EDT

Short Sellers Get Selective on Major Pharma

The short interest data have been released for the July 15 settlement date. For the selected pharmaceutical stocks, short interest…

Trey Thoelcke | Jul 14, 2016 at 12:20 PM EDT

Why Teva’s $20 Billion Bond Sale Makes Sense, as Long as It’s a Fixed Rate

Lucky for Teva Pharmaceuticals, interest rates on all kinds of debt have never been lower in recorded human history, and…

Chris Lange | Jul 13, 2016 at 10:55 AM EDT

Why the Teva Acquisition Proves It Is a Stock to Own for the Decade

Even though the trend toward generic drugs is only likely to grow, the drug price pressures hanging over the sector…

Chris Lange | Jul 13, 2016 at 9:15 AM EDT

Short Sellers Run for Cover From Major Pharma

The June 30 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short…

Douglas A. McIntyre | Jul 9, 2016 at 9:25 AM EDT

Viagra Price Drops 50% as Drug Faces Competition

Viagra, the wildly successful erectile dysfunction pill, faces challenges from a generic version that will launch next year.

Chris Lange | Jul 3, 2016 at 7:38 AM EDT

How Major Pharma Is Faring After the Brexit

The broad markets are recovering in the wake of the Brexit and it really appears to be one big head…

Chris Lange | Jun 27, 2016 at 8:11 AM EDT

Short Sellers Increase Bets Against Major Pharmaceutical Stocks

The short interest data have been released for the June 15 settlement date. Pharmaceutical companies usually are involved in a…

1 … 15 16 17 18 19 … 30

Teva : TEVA

All Teva Articles

Top Analyst Upgrades and Downgrades: Carnival, Ciena, MercadoLibre, Spark Therapeutics, Smith & Wesson, Teva, Verifone and More

Top Analyst Upgrades and Downgrades: DDR, HP, L-3 Communications, Salesforce.com, Teva, Twilio and More

Major Pharma Short Interest Faces Significant Drop

Major Pharma Short Interest Slides

Why Allergan Earnings Aren’t Telling the Whole Story

Top Analyst Upgrades and Downgrades: FireEye, Occidental Petroleum, SeaWorld, Teva Pharma, Windstream, Zynga and More

What Expect From Teva Earnings

The Top 10 Earnings for the Week Ahead

Short Sellers Get Selective on Major Pharma

Why Teva’s $20 Billion Bond Sale Makes Sense, as Long as It’s a Fixed Rate

Why the Teva Acquisition Proves It Is a Stock to Own for the Decade

Short Sellers Run for Cover From Major Pharma

Viagra Price Drops 50% as Drug Faces Competition

How Major Pharma Is Faring After the Brexit

Short Sellers Increase Bets Against Major Pharmaceutical Stocks

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Teva : TEVA

All Teva Articles

Top Analyst Upgrades and Downgrades: Carnival, Ciena, MercadoLibre, Spark Therapeutics, Smith & Wesson, Teva, Verifone and More

Top Analyst Upgrades and Downgrades: DDR, HP, L-3 Communications, Salesforce.com, Teva, Twilio and More

Major Pharma Short Interest Faces Significant Drop

Major Pharma Short Interest Slides

Why Allergan Earnings Aren’t Telling the Whole Story

Top Analyst Upgrades and Downgrades: FireEye, Occidental Petroleum, SeaWorld, Teva Pharma, Windstream, Zynga and More

What Expect From Teva Earnings

The Top 10 Earnings for the Week Ahead

Short Sellers Get Selective on Major Pharma

Why Teva’s $20 Billion Bond Sale Makes Sense, as Long as It’s a Fixed Rate

Why the Teva Acquisition Proves It Is a Stock to Own for the Decade

Short Sellers Run for Cover From Major Pharma

Viagra Price Drops 50% as Drug Faces Competition

How Major Pharma Is Faring After the Brexit

Short Sellers Increase Bets Against Major Pharmaceutical Stocks

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Featured Reads

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do